Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01523899 · ClinicalTrials.gov registry record · NA
Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses
A NA study of Cutaneous Abscess, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 2
- Study locations
NCT01523899: Completed NA study of Cutaneous Abscess, sponsored by George Washington University.
NCT01523899 is a NA study of Cutaneous Abscess that has completed, run by George Washington University. The registered enrollment target is 252 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01523899, a NA study of Cutaneous Abscess, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study expands upon pilot data for feasibility since May 2011. The study aims to evaluate the effect of rapid test availability on use of targeted spectrum antibiotics for non-MRSA abscesses in ambulatory patients in the Emergency Department (ED). The multi-institutional study will assess the feasibility of providing the GeneXpert® MRSA/SA SSTI assay to the ED and evaluate the impact of delivering the test result to clinicians in real-time on patient management decisions regarding the use of antimicrobial agents. Patients are randomized to standard culture (control arm) or to the GeneXpert® assay plus standard culture.
Primary Outcome
Number of Participants with Antibiotic Usage at the time of the ED visit (narrow spectrum, broad spectrum, or none) will be recorded at the time of the ED visit
Conditions Studied
Interventions
- DEVICE Xpert MRSA/SA SSTI
- DIAGNOSTIC_TEST Standard culture
Study Locations (2)
District of Columbia
- The George Washington University - Washington D.C.
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2011-05 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT01523899 record still lists
NCT01523899 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Cutaneous Abscess appearing as the primary indexed condition, and to 2 interventions - of which Xpert MRSA/SA SSTI is the first listed.
NCT01523899 reports a single indexed study location in District of Columbia, Maryland.
Frequently Asked Questions
What is clinical trial NCT01523899 about?
NCT01523899 is a clinical study titled "Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses". This study expands upon pilot data for feasibility since May 2011. The study aims to evaluate the effect of rapid test availability on use of targeted spectrum antibiotics for non-MRSA abscesses in ambulatory patients in the Emergency Department (ED). The multi-institutional study will assess the fe...
What is the current status of trial NCT01523899?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2011-05. Estimated completion is 2015-01.
What conditions does trial NCT01523899 study?
This clinical trial studies the following conditions: Cutaneous Abscess.
What interventions are being tested in trial NCT01523899?
The interventions under investigation include: Xpert MRSA/SA SSTI (DEVICE), Standard culture (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01523899?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01523899 being conducted?
This trial has 2 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cutaneous Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01523899's enrollment target sits among peer trials
252 407th of 2000 higher than 1,591 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia